Interim analysis of Axcan's Phase II Urso data

An interim analysis of 258 patients in a 716-patient Phase II trial of Urso ursodeoxycholic acid (UDCA) to treat or prevent the recurrence of adenomatous colorectal polyps in the U.S. and Canada revea...